Skip to main content
Clinical Trials/ACTRN12621000205831
ACTRN12621000205831
Recruiting
未知

RASKAL: Robotic-assisted surgery and kinematic alignment in total knee arthroplasty. A registry-nested, multi-centre, 2 x 2 factorial randomised trial of clinical, functional, radiographic and survivorship outcomes

Australian Orthopaedic Association National Joint Replacement Registry0 sites300 target enrollmentFebruary 26, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
End Stage Arthritis
Sponsor
Australian Orthopaedic Association National Joint Replacement Registry
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Australian Orthopaedic Association National Joint Replacement Registry

Eligibility Criteria

Inclusion Criteria

  • 1\.All patients suitable for TKA age 40\-80 years with a primary diagnosis of osteoarthritis.
  • 2\.Patients who meet the indications for primary unilateral TKA using the Stryker Triathlon cruciate\-retaining TKA system.

Exclusion Criteria

  • 1\.Knee flexion \< 90 degrees and knee flexion contracture \> 15 degrees at preoperative assessment
  • 2\.Coronal deformity with hip\-knee\-ankle (HKA) angle \> 15 degrees varus and \> 10 degrees valgus on standing long\-leg radiographs
  • 3\.Prior grade 3 injury to posterior cruciate ligament, posterolateral corner, lateral collateral ligament or medial collateral ligament
  • 4\.TKA requiring increased prosthetic stability (posterior\-stabilised, constrained condylar, or rotating hinge designs), diaphyseal stems or metal augments
  • 5\.TKA for causes other than osteoarthritis (inflammatory arthritis, post\-traumatic arthritis, tumour or acute fracture)
  • 6\.Prior contralateral TKA within 6 months of current TKA surgery
  • 7\.Any prior knee surgery apart from arthroscopic surgery or anterior cruciate ligament reconstruction
  • 8\.Prior femoral, tibial or patellofemoral osteotomies
  • 9\.Symptomatic grade 3\-4 ipsilateral ankle or hip arthritis
  • 10\.The participant unable to attend clinical follow\-up for a minimum of 2 years

Outcomes

Primary Outcomes

Not specified

Similar Trials